Skip to content

Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM

Morbidity and Functional Outcome of Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM in Obstructed Defecation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00673400
Acronym
STARR
Enrollment
52
Registered
2008-05-07
Start date
2008-01-31
Completion date
2009-11-30
Last updated
2012-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intussusception, Obstructed Defecation Syndrome, Rectocele, SNS

Keywords

Obstructed defecation syndrome, ODS, Rectocele, Intussusception, STARR

Brief summary

The stapled transanal rectal resection (STARR procedure) is an effective treatment for obstructed defecation syndrome (ODS) caused by intussusception and rectocele. Recently a new technique has been developed using the new Contour® TranstarTM stapler, which was specifically designed to facilitate the STARR procedure. The investigators would like to evaluate the morbidity and quality of life.

Interventions

PROCEDUREStapled transanal rectum resection

Contour Transtar-STR5G (Ethicon EndoSurgery Inc., Cincinnati, OH).The circular anal dilator is fixed to perianal skin.Rectal intussusception is evidenced with a swab.The first stitch is placed superficial on top of the intussusception. The procedure is performed 5to6 times counterclockwise.A final stitch for first radial cut at 3 o'clock.The device is introduced into the rectum. This cut opens the prolapse. Check with a finger the vagina. The device is then closed and fired. After replacing the cartridge, the device is introduced in the rectum, placed parallel to the circular anal dilator and moved counter clockwise with 4to6firings to complete the resection. Additional stitches across the staple line to assure haemostasis.

Sponsors

Cantonal Hospital of St. Gallen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Rectocele * Intussusception

Exclusion criteria

* Non operability * inflammatory bowel disease

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life6 months after interventionQuality of life is measured by Fecal incontinence quality of life (FIQL) Possible range of score 0 - 4 (Depression/Self perception 4.4) 0 = worst condition * Fecal Incontinence Quality of Life (FIQL) (Rockwood, Dis Colon Rectum (2000) 43:9)

Secondary

MeasureTime frameDescription
Morbidity1 yearSurgical complications after treatment according to Dindo (Ann Surg (2004) 240:205)
Hospitalization1 day to 1 year (until release from hospital)Length of hospital stay (Date of release - Date of admission + 1)

Other

MeasureTime frameDescription
Severity of Symptoms Scorebefore surgery - 6 weeks - 3 months - 6 monthsScore based on the severity of 9 symptoms of bowel movement (physician administered) (0 - 36, no symptoms = 0) Dis Colon Rectum 39:681 (DOI: 10.1007/BF02056950)
Obstructive Defecation Syndrome Scorebefore surgery - 6 weeks -3 months - 6 monthsScore based on severity or frequency of 9 symptoms of obstructive defecation (physician administered) (0 - 40, no symptoms = 0) Dis Colon Rectum 51:348(DOI: 10.1007/s10350-007-9115-1)
SF36 Component Summary ScoresBefore surgery - 6 monthsQuality of life short form 36 version 2(SF36v2) standard form PCS: physical component summary score (range 1 to 81, with 81 being the best) MCS: mental component summary score (range -9 to 82, with 82 being the best) A score of 50 correlates with the result of a healthy standard US population (score transformation to a mean of 50 and a standard deviation of 10) Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36® Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.

Countries

Switzerland

Participant flow

Participants by arm

ArmCount
Stapled TransAnal Rectal Resection
patients were operated by stapled transanal rectal resection
52
Total52

Baseline characteristics

CharacteristicStapled TransAnal Rectal Resection
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
23 Participants
Age, Categorical
Between 18 and 65 years
29 Participants
Age Continuous63.2 years
STANDARD_DEVIATION 12.9
Region of Enrollment
Switzerland
52 participants
Sex: Female, Male
Female
52 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
4 / 52
serious
Total, serious adverse events
0 / 52

Outcome results

Primary

Quality of Life

Quality of life is measured by Fecal incontinence quality of life (FIQL) Possible range of score 0 - 4 (Depression/Self perception 4.4) 0 = worst condition * Fecal Incontinence Quality of Life (FIQL) (Rockwood, Dis Colon Rectum (2000) 43:9)

Time frame: 6 months after intervention

Population: Participating in the FIQL survey was voluntarily. Some patients did not participate at all, some did not answer all questions. Patients answering \>=50% of questions of a domain were counted as participants

ArmMeasureGroupValue (MEDIAN)
Before SurgeryQuality of LifeLifestyle (LS)3.2 units on a scale
Before SurgeryQuality of LifeEmbarrassment (E)3.3 units on a scale
Before SurgeryQuality of LifeCoping/behavior (C/P)2.8 units on a scale
Before SurgeryQuality of LifeDepression/self-perception (D/S)3.3 units on a scale
6 Months After SurgeryQuality of LifeEmbarrassment (E)4.0 units on a scale
6 Months After SurgeryQuality of LifeLifestyle (LS)3.7 units on a scale
6 Months After SurgeryQuality of LifeDepression/self-perception (D/S)3.9 units on a scale
6 Months After SurgeryQuality of LifeCoping/behavior (C/P)3.3 units on a scale
Comparison: Lifestyle (LS)p-value: 0.134Wilcoxon (Mann-Whitney)
Comparison: Coping/behavior (C/B)p-value: 0.088Wilcoxon (Mann-Whitney)
Comparison: Depression/self-perception (D/S)p-value: 0.0012Wilcoxon (Mann-Whitney)
Comparison: Embarrassment (E)p-value: 0.0074Wilcoxon (Mann-Whitney)
Secondary

Hospitalization

Length of hospital stay (Date of release - Date of admission + 1)

Time frame: 1 day to 1 year (until release from hospital)

ArmMeasureValue (MEDIAN)
Before SurgeryHospitalization5 days
Secondary

Morbidity

Surgical complications after treatment according to Dindo (Ann Surg (2004) 240:205)

Time frame: 1 year

ArmMeasureGroupValue (NUMBER)
Before SurgeryMorbidityUrinay retention (Dindo IIIa) (within 30 days)1 participants
Before SurgeryMorbidityself limiting rectal bleeding (Dindo I)(6 weeks)2 participants
Before SurgeryMorbidityPain from residual staple (Dindo IIIa)(6 weeks)2 participants
Before SurgeryMorbidityPerianal venous thrombosis (Dindo IIIa) (5 weeks)1 participants
Before SurgeryMorbidityoverall6 participants
Other Pre-specified

Obstructive Defecation Syndrome Score

Score based on severity or frequency of 9 symptoms of obstructive defecation (physician administered) (0 - 40, no symptoms = 0) Dis Colon Rectum 51:348(DOI: 10.1007/s10350-007-9115-1)

Time frame: before surgery - 6 weeks -3 months - 6 months

ArmMeasureValue (MEDIAN)
Before SurgeryObstructive Defecation Syndrome Score16 units on a scale
6 Months After SurgeryObstructive Defecation Syndrome Score5 units on a scale
3 Months After SurgeryObstructive Defecation Syndrome Score4 units on a scale
6 Months After SurgeryObstructive Defecation Syndrome Score5 units on a scale
p-value: <1e-7Wilcoxon (Mann-Whitney)
p-value: <1e-7Wilcoxon (Mann-Whitney)
p-value: <1e-7Wilcoxon (Mann-Whitney)
Other Pre-specified

Severity of Symptoms Score

Score based on the severity of 9 symptoms of bowel movement (physician administered) (0 - 36, no symptoms = 0) Dis Colon Rectum 39:681 (DOI: 10.1007/BF02056950)

Time frame: before surgery - 6 weeks - 3 months - 6 months

ArmMeasureValue (MEDIAN)
Before SurgerySeverity of Symptoms Score15 units on a scale
6 Months After SurgerySeverity of Symptoms Score4 units on a scale
3 Months After SurgerySeverity of Symptoms Score3 units on a scale
6 Months After SurgerySeverity of Symptoms Score3 units on a scale
p-value: <1e-7Wilcoxon (Mann-Whitney)
p-value: <1e-7Wilcoxon (Mann-Whitney)
p-value: <1e-7Wilcoxon (Mann-Whitney)
Other Pre-specified

SF36 Component Summary Scores

Quality of life short form 36 version 2(SF36v2) standard form PCS: physical component summary score (range 1 to 81, with 81 being the best) MCS: mental component summary score (range -9 to 82, with 82 being the best) A score of 50 correlates with the result of a healthy standard US population (score transformation to a mean of 50 and a standard deviation of 10) Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36® Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.

Time frame: Before surgery - 6 months

ArmMeasureGroupValue (MEDIAN)
Before SurgerySF36 Component Summary ScoresPhysical component summary (PCS)51 units on a scale
Before SurgerySF36 Component Summary ScoresMental component summary (MCS)39 units on a scale
6 Months After SurgerySF36 Component Summary ScoresPhysical component summary (PCS)52 units on a scale
6 Months After SurgerySF36 Component Summary ScoresMental component summary (MCS)53 units on a scale
Comparison: Physical component summary (PCS)p-value: 0.65Wilcoxon (Mann-Whitney)
Comparison: Mental component summary (MCS)p-value: 0.01Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026